ACCESS HUB

Serial Number 98493564
688

Registration Progress

Application Filed
Apr 10, 2024
Under Examination
May 6, 2025
Approved for Publication
Mar 11, 2025
Published for Opposition
Mar 11, 2025
Registered

Basic Information

Serial Number
98493564
Deadline
November 6, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
April 10, 2024
Published for Opposition
March 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
May 6, 2025
Application
Pending
Classes
009 035 036 042
+1 more

Rights Holder

IPD Analytics, LLC

16
Address
19950 W Country Club Drive, 7th Floor
Aventura, FL 33180

Ownership History

IPD Analytics, LLC

Original Applicant
16
Aventura, FL

IPD Analytics, LLC

Original Applicant
16
Aventura, FL

IPD Analytics, LLC

Owner at Publication
16
Aventura, FL

IPD Analytics, LLC

Owner at Publication
16
Aventura, FL

Legal Representation

Attorney
Julie A. Greenberg

Application History

36 events
Date Code Type Description
May 6, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 19, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
Feb 19, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 19, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
Feb 19, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2024 GNRT F NON-FINAL ACTION E-MAILED
Oct 30, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRT F NON-FINAL ACTION E-MAILED
Oct 30, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 23, 2024 DOCK D ASSIGNED TO EXAMINER
Sep 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2024 NWAP I NEW APPLICATION ENTERED
Apr 10, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 009
Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs
Class 035
Business and commercial pharmaceutical market analysis and information services; Gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the nature of providing business and commercial information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets in the nature of providing business and commercial information providing business information and market analysis services in the field of pharmaceuticals
Class 036
Gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the nature of financial and insurance information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; providing financial and insurance information, data, and analytics in the nature of financial and insurance information in the field of pharmaceuticals and pharmaceutical markets; Financial analysis and insurance information services in the field of pharmaceutical markets
Class 042
Gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the nature of providing scientific information and scientific research information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) featuring software for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics in the nature of providing scientific information and scientific research information regarding pharmaceuticals; Scientific and scientific research information analysis services in the nature of providing scientific information, scientific research information and scientific analysis in the field of pharmaceuticals; Software as a service (SAAS) featuring software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals
Class 044
Medical information relating to medical, therapeutic, pharmacological, and pharmaceutical fields; Medical information and medical analysis relating to medical, therapeutic, pharmacological, and pharmaceutical fields for diagnostic and treatment purposes provided by medical laboratories; Gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the nature of medical information in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing medical research information in the field of pharmaceuticals

Classification

International Classes
009 035 036 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ACCESS"
Specific Disclaimer
"ACCESS"